Back to top

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to ...

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C | ZVRA Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Zevra Therapeutics, Inc. (ZVRA)